Uranium Energy (UEC) Stock Forecast & Price Target (2026)
π UEC trades at $7.89 with a market cap of $3.92B but lacks profitability, showing negative trailing earnings and a P/E ratio that does not exist.
πΈ Revenue collapsed by 100% in the latest quarter compared to the prior year, contributing to a fiscal 2025 net loss of $87.7M.
π The company missed its EPS estimate by 140% in the most recent report dated September 29, 2026, failing to beat expectations for seven consecutive quarters.
π Technical analysis indicates a strong downtrend with the stock price 38.69% below its 200-day moving average and 50.56% down over the past year.
π€ Analyst consensus is mixed, with 8 of 11 Wall Street analysts rating UEC as Buy or Strong Buy despite a median target of $15.00.
π Insider sentiment is negative, showing no open-market purchases by directors or officers in the last 18 months and net sales of $489K.
π Long-term performance shows UEC beat the S&P 500 over a decade-long period, growing a $10k investment to roughly $85k compared to $41k for the benchmark.
β οΈ The stock exhibits high volatility with a beta of 1.39 against the S&P 500 and an RSI in the bearish zone at 32.4.
- Eight out of eleven Wall Street analysts rate Uranium Energy Corp as Buy or Strong Buy, indicating confidence in future upside despite current losses.
- Analysts have set a median 12-month price target of $15.00, implying a potential gain of 90.2% from the current trading price of $7.89.
- Historical data demonstrates that UEC significantly outperformed the S&P 500 over a ten-year period, turning a $10,000 investment into approximately $85,054.
- Revenue fell 100% in the latest quarter compared to the same quarter a year earlier, signaling severe contraction in top-line growth.
- UEC has failed to beat analyst EPS estimates for seven consecutive quarters, with the most recent miss being 140% below consensus.
- The stock is trading in a downtrend, sitting 38.69% below its 200-day moving average and 50.56% lower than its price one year ago.
- Insider activity has been purely negative with no open-market purchases by directors or officers in the last 18 months and net sales of $489K.